A novel bioavailable hydrogenated curcuminoids formulation (CuroWhite™) improves symptoms and diagnostic indicators in rheumatoid arthritis patients - A randomized, double blind and placebo controlled study

Rheumatoid arthritis (RA) is an inflammatory disease that cause chronic pain, disability and joint destruction. The present placebo controlled randomized study aimed to evaluate the efficacy of a novel hydrogenated curcuminoid formulation-CuroWhite™, in rheumatoid arthritis (RA) patients. Twenty fou...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Tradit Complement Med
Main Authors: Jacob, Joby, Amalraj, Augustine, Raj, K.K. Jithin, Divya, Chandradhara, Kunnumakkara, Ajaikumar B., Gopi, Sreeraj
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2018
Assuntos:
Original article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6702143/
https://ncbi.nlm.nih.gov/pubmed/31453131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcme.2018.06.001
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares